Holen Sie sich die Stockscreener-App
26.35
1.19%
0.31
Handel nachbörslich:
26.41
0.06
+0.23%
Schlusskurs vom Vortag:
$26.04
Offen:
$25.93
24-Stunden-Volumen:
1.97M
Relative Volume:
0.45
Marktkapitalisierung:
$4.70B
Einnahmen:
$644.86M
Nettoeinkommen (Verlust:
$196.05M
KGV:
26.85
EPS:
0.9812
Netto-Cashflow:
$317.50M
1W Leistung:
+0.92%
1M Leistung:
+6.51%
6M Leistung:
+8.97%
1J Leistung:
-64.57%
1-Tages-Spanne:
$25.72
$26.62
1-Wochen-Bereich:
$25.72
$27.48
52-Wochen-Spanne:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, TXG, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
26.35 | 4.70B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
280.68 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
85.01 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.59 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
85.71 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
95.57 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Herabstufung | Truist | Buy → Hold |
| 2026-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionDOCS - TMX Newsfile
Deadline Soon: Doximity, Inc. (DOCS) Shareholders Who Lost Money - The National Law Review
Did You Lose Money on Doximity, Inc. (DOCS)? Levi & Korsinsky Urges Investors to Act Before November 16, 2026 - ACCESS Newswire
DOCS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Doximity, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Doximity, Inc. (DOCS) LawsuitInvestors Urged to Contact Levi & Korsinsky Before November 16, 2026 - ACCESS Newswire
Securities Class Action Lawsuit Filed Against Doximity, Inc. (DOCS)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
DEADLINE ALERT for BIDU, DOCS, BETR, and HONA : The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - GlobeNewswire Inc.
Kaplan Fox Encourages Investors of Doximity, Inc. (NYSE: DOCS) to - The National Law Review
Investors Urged to Contact Levi & Korsinsky for Information Before November 16, 2026Doximity, Inc. (DOCS) - ACCESS Newswire
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law - Carroll County Mirror-Democrat
Kaplan Fox Encourages Investors of Doximity, Inc. (NYSE: DOCS) to Contact the Firm Before Lead Plaintiff Deadline on November 16, 2026 - Barchart.com
Doximity, Inc. (DOCS) stock price, news, quote and history - Yahoo Finance Australia
Lost Money on Doximity, Inc. (DOCS)? Urged to Join Class Action Before November 16, 2026Contact Levi & Korsinsky - ACCESS Newswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionDOCS - TMX Newsfile
Class Action Filed Against Doximity, Inc. (DOCS) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming DeadlinesDOCS - prnewswire.com
DOCS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Doximity, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Lost Money on Doximity, Inc. (DOCS)? Contact Levi & Korsinsky to Join Class Action Before November 16, 2026 - ACCESS Newswire
Class Action Lawsuit Filed: Doximity, Inc. (DOCS)Join by November 16, 2026Contact Levi & Korsinsky - ACCESS Newswire
DOCS Shareholder Alert: Doximity, Inc. Securities Class Action LawsuitInvestors With Losses May Contact SueWallSt - prnewswire.com
Important Notice to Long-Term Shareholders of Doximity, - GlobeNewswire
Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year? - Trefis
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo! Finance Canada
Contact Levi & Korsinsky by November 16, 2026 to Join Class Action Against Doximity, Inc. (DOCS) - ACCESS Newswire
DOCS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Doximity, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Join Class Action to Recover Losses from Doximity, Inc. (DOCS) – Contact Levi & Korsinsky Before November 16, 2026 - ACCESS Newswire
November 16, 2026 Deadline Approaching: Join Class Action Against Doximity, Inc. (DOCS)Contact Levi & Korsinsky - ACCESS Newswire
Join Class Action to Recover Losses From Doximity, Inc. (DOCS)Contact Levi & Korsinsky Before November 16, 2026 - ACCESS Newswire
Shareholders who lost money in shares of acquired Doximity, - GlobeNewswire
Kaplan Fox Reminds Investors of Doximity, Inc. (NYSE: DOCS) to a - The National Law Review
DOCS Class Action ReminderRobbins LLP Reminds Investors - GlobeNewswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionDOCS - TMX Newsfile
Law Offices of Frank R. Cruz Encourages Doximity, Inc. (DOCS) Shareholders To Inquire About Securities Fraud Class Action - The Daily Tribune News
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Doximity, Inc. LawsuitDOCS - prnewswire.com
Could Doximity (NYSE:DOCS) surprise a selective market? - kalkinemedia.com
Doximity, Inc. (DOCS) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 16, 2026 Deadline - ACCESS Newswire
What Doximity (DOCS)'s Bedside Bench AI Benchmark Launch Means For Shareholders - finance.yahoo.com
Doximity Named Leading Clinical AI Benchmark in Fireworks’ Cross-Industry Index - 01net
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit - The Conway Daily Sun
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline - Supply Chain Digital Magazine
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS - FinancialContent
DOXIMITY LAWSUIT ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
DOCS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
DOCS INVESTOR ALERT: Doximity, Inc. Investors with - GlobeNewswire
DOCS INVESTOR DEADLINE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP AnnouncesNovember 16, 2026 Deadline - FinancialContent
Securities Fraud Investigation Into Doximity, Inc. (DOCS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - FinancialContent
Kaplan Fox Encourages Investors of Doximity, Inc. (NYSE: DOCS) to Contact the Firm to Learn About Their Legal Rights - Barchart.com
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing - finance.yahoo.com
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):